WHO ICTRP trial
Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome
EUCTR2014-004029-41-NO · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2014-004029-41-NO |
|---|---|
| Public title | Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome |
| Scientific title | Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An open label phase-II study with 6 infusions of cyclophosphamide 4 weeks apart. - Cyclophosphamide in ME/CFS |
| Primary sponsor | Department of Oncology, Haukeland University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Norway |
| Conditions | Chronic Fatigue Syndrome/ Myalgic Encephalopathy, as defined by Canadian Consensus Criteria (2003) MedDRA version: 18.0 Level: PT Classification code 10008874 Term: Chronic fatigue syndrome System Organ Class: 10018065 - General disorders… |
| Interventions | Trade Name: Sendoxan Pharmaceutical Form: Concentrate and solvent for solution for infusion |
| Registration date | Oct 22, 2014 |
| Target size | 30 |
| Secondary IDs | KTS-7-2015 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: